EP1401427A4 - Agents gnrh non peptidiques, compositions pharmaceutiques et methodes d'utilisation de ces dernieres, procedes de preparation de ces composes - Google Patents
Agents gnrh non peptidiques, compositions pharmaceutiques et methodes d'utilisation de ces dernieres, procedes de preparation de ces composesInfo
- Publication number
- EP1401427A4 EP1401427A4 EP02739712A EP02739712A EP1401427A4 EP 1401427 A4 EP1401427 A4 EP 1401427A4 EP 02739712 A EP02739712 A EP 02739712A EP 02739712 A EP02739712 A EP 02739712A EP 1401427 A4 EP1401427 A4 EP 1401427A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- preparing
- processes
- methods
- pharmaceutical compositions
- peptide gnrh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29581201P | 2001-06-06 | 2001-06-06 | |
US295812P | 2001-06-06 | ||
US30186801P | 2001-06-29 | 2001-06-29 | |
US301868P | 2001-06-29 | ||
PCT/US2002/017846 WO2002098363A2 (fr) | 2001-06-06 | 2002-06-05 | Agents gnrh non peptidiques, compositions pharmaceutiques et methodes d'utilisation de ces dernieres, procedes de preparation de ces composes et de leurs intermediaires |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1401427A2 EP1401427A2 (fr) | 2004-03-31 |
EP1401427A4 true EP1401427A4 (fr) | 2004-12-01 |
Family
ID=26969346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02739712A Withdrawn EP1401427A4 (fr) | 2001-06-06 | 2002-06-05 | Agents gnrh non peptidiques, compositions pharmaceutiques et methodes d'utilisation de ces dernieres, procedes de preparation de ces composes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1401427A4 (fr) |
JP (1) | JP2005501006A (fr) |
AU (1) | AU2002312348A1 (fr) |
BR (1) | BR0210191A (fr) |
CA (1) | CA2449843A1 (fr) |
MX (1) | MXPA03011002A (fr) |
WO (1) | WO2002098363A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0130341D0 (en) | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
US7205307B2 (en) * | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
BR0312123A (pt) * | 2002-06-13 | 2005-03-29 | Pfizer | Agentes de gnrh não peptìdicos, composições farmacêuticas e métodos para o seu uso |
US7332521B2 (en) * | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
EP1541549A1 (fr) * | 2003-12-12 | 2005-06-15 | Exonhit Therapeutics S.A. | Dérivés tricycliques d'hydroxamate et de benzamide, compositions et methodes |
KR101433629B1 (ko) | 2006-09-11 | 2014-08-27 | 쿠리스 인코퍼레이션 | 아연 결합 부분을 함유한 티로신 키나아제 억제제 |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
CN102329234B (zh) * | 2011-06-24 | 2013-11-06 | 灌南伊斯特化工有限公司 | 一种间硝基苯甲醛的生产工艺 |
EP2712862A1 (fr) * | 2012-09-28 | 2014-04-02 | Splicos | Nouveaux composés anti-invasifs |
US20160058895A1 (en) * | 2013-04-19 | 2016-03-03 | Oslo Universitetssykehus Hf | Radiolabeled gnrh antagonists as pet imaging agents |
CN108905641B (zh) * | 2018-08-01 | 2020-04-28 | 湖南七纬科技有限公司 | 一种纳滤膜及其制备方法 |
CN114105775A (zh) * | 2021-11-30 | 2022-03-01 | 武汉工程大学 | 一种带有末端双键的取代碘苯的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999044987A1 (fr) * | 1998-03-05 | 1999-09-10 | Agouron Pharmaceuticals, Inc. | AGENTS NON-PEPTIDIQUES ANTI-GnRH |
WO2000020358A2 (fr) * | 1998-08-20 | 2000-04-13 | Agouron Pharmaceuticals, Inc. | Agents non peptidiques de l'hormone de liberation de la gonadotrophine et intermediaires utiles pour les preparer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU751139B2 (en) * | 1997-10-13 | 2002-08-08 | Astellas Pharma Inc. | Amide derivative |
-
2002
- 2002-06-05 CA CA002449843A patent/CA2449843A1/fr not_active Abandoned
- 2002-06-05 AU AU2002312348A patent/AU2002312348A1/en not_active Abandoned
- 2002-06-05 MX MXPA03011002A patent/MXPA03011002A/es not_active Application Discontinuation
- 2002-06-05 JP JP2003501405A patent/JP2005501006A/ja not_active Withdrawn
- 2002-06-05 WO PCT/US2002/017846 patent/WO2002098363A2/fr not_active Application Discontinuation
- 2002-06-05 EP EP02739712A patent/EP1401427A4/fr not_active Withdrawn
- 2002-06-05 BR BR0210191-2A patent/BR0210191A/pt not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999044987A1 (fr) * | 1998-03-05 | 1999-09-10 | Agouron Pharmaceuticals, Inc. | AGENTS NON-PEPTIDIQUES ANTI-GnRH |
WO2000020358A2 (fr) * | 1998-08-20 | 2000-04-13 | Agouron Pharmaceuticals, Inc. | Agents non peptidiques de l'hormone de liberation de la gonadotrophine et intermediaires utiles pour les preparer |
Also Published As
Publication number | Publication date |
---|---|
CA2449843A1 (fr) | 2002-12-12 |
BR0210191A (pt) | 2004-04-06 |
AU2002312348A1 (en) | 2002-12-16 |
WO2002098363A2 (fr) | 2002-12-12 |
EP1401427A2 (fr) | 2004-03-31 |
MXPA03011002A (es) | 2004-10-28 |
WO2002098363A3 (fr) | 2003-03-20 |
JP2005501006A (ja) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402560A3 (en) | N-adamantylmethyl derivates, processes for their preparation, pharmaceutical compositions thereof and intermediates | |
HUP0402264A3 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof | |
MXPA03006775A (es) | Formulacion farmaceutica. | |
HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
HUP0402225A3 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
GB0111597D0 (en) | Pharmaceutical compositions | |
MXPA03007641A (es) | Formulacion farmaceutica. | |
GB0118689D0 (en) | Pharmaceutical formulation | |
HUP0400040A2 (hu) | Szulfonamidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
EP1401427A4 (fr) | Agents gnrh non peptidiques, compositions pharmaceutiques et methodes d'utilisation de ces dernieres, procedes de preparation de ces composes | |
AU2003233127A1 (en) | Non-peptide gnrh agents, pharmaceutical compositions and methods for their use | |
HUP0401082A3 (en) | Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them | |
GB0124523D0 (en) | Pharmaceutical combination | |
SI1392722T1 (sl) | Postopek za pripravo ehinokandina | |
HUP0303469A3 (en) | Phtalazinon-derivatives, their use and pharmaceutical compositions containing them | |
HUP0401644A3 (en) | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof | |
ZA200404807B (en) | Imidazoquinoline derivatives. | |
GB0104752D0 (en) | Pharmaceutical compositions | |
GB0129270D0 (en) | Pharmaceutical combination | |
GB0129397D0 (en) | Pharmaceutical combination | |
HUP0401038A3 (en) | Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them | |
GB0127720D0 (en) | Pharmaceutical compositions | |
GB0129395D0 (en) | Pharmaceutical combination | |
IL159561A0 (en) | Eurotinones and derivatives thereof, processes for preparing them, and their use | |
GB0104749D0 (en) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040107 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VAZIR, HARESH Inventor name: TRUESDALE, LARRY, KENNETH Inventor name: TOMPKINS, EILEEN, VALENZUELA Inventor name: SHACKELFORD, SCOTT Inventor name: RAJAPAKSE, RANJAN, JAGATH Inventor name: PATHAK, VED, P. Inventor name: PADERES, GENEVIEVE, D. Inventor name: LUTHIN, DAVID, ROBERT Inventor name: LI, HAITAO Inventor name: KRAYNOV, EUGENIA, ANATOLIEVNA Inventor name: HONG, YUFENG Inventor name: GOETZEN, THOMAS Inventor name: FENG, JUN Inventor name: DO, QUYEN-QUYEN, THUY Inventor name: CHRISTIE, LANCE, CHRISTOPHER Inventor name: ANDERES, KENNA, LYNN Inventor name: ANDERSON, MARK, B. Inventor name: SUN, ERIC, T. |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: VAZIR, HARESH Inventor name: TRUESDALE, LARRY, KENNETH Inventor name: TOMPKINS, EILEEN, VALENZUELA Inventor name: SHACKELFORD, SCOTT Inventor name: RAJAPAKSE, RANJAN, JAGATH Inventor name: PATHAK, VED, P. Inventor name: PADERES, GENEVIEVE, D. Inventor name: LUTHIN, DAVID, ROBERT Inventor name: LI, HAITAO Inventor name: KRAYNOV, EUGENIA, ANATOLIEVNA Inventor name: HONG, YUFENG Inventor name: GOETZEN, THOMAS Inventor name: FENG, JUN Inventor name: DO, QUYEN-QUYEN, THUY Inventor name: CHRISTIE, LANCE, CHRISTOPHER Inventor name: ANDERES, KENNA, LYNN Inventor name: ANDERSON, MARK, B. Inventor name: SUN, ERIC, T. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AGOURON PHARMACEUTICALS, INC. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041014 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 35/00 B Ipc: 7A 61P 15/00 B Ipc: 7C 07D 307/68 B Ipc: 7C 07D 405/14 B Ipc: 7C 07D 405/12 B Ipc: 7C 07D 405/10 B Ipc: 7C 07D 307/58 B Ipc: 7A 61K 31/497 B Ipc: 7A 61K 31/443 B Ipc: 7A 61K 31/341 A |
|
17Q | First examination report despatched |
Effective date: 20070226 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070710 |